-transparent.png){kind=logo}
When adenovirus type 5-infected HeLa cells were exposed to the tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate, short pulse-labeling with [3H]uridine in vivo and [3H]UTP incorporation by isolated nuclei in vitro were both consistent with a decreased latent period before initiation by RNA polymerase at early viral promoters. Acceleration was not dependent upon concurrent protein synthesis and could not be attributed to rapid entry of virus into the cell nucleus. 12-O-tetradecanoyl-phorbol-13-acetate suppressed the transcription-delay phenotype of the E1a mutant, hr1, without restoring its ability to replicate.
Related Publications
T H Carter, and
Z Z Milovanovic, and
L E Babiss, and
P B Fisher
April 1979,
FEBS letters,
T H Carter, and
Z Z Milovanovic, and
L E Babiss, and
P B Fisher
October 1981,
Experimental cell research,
T H Carter, and
Z Z Milovanovic, and
L E Babiss, and
P B Fisher
April 1979,
Biochemical and biophysical research communications,
T H Carter, and
Z Z Milovanovic, and
L E Babiss, and
P B Fisher
February 1984,
European journal of pharmacology,
T H Carter, and
Z Z Milovanovic, and
L E Babiss, and
P B Fisher
January 1978,
Journal of environmental pathology and toxicology,
T H Carter, and
Z Z Milovanovic, and
L E Babiss, and
P B Fisher
February 1974,
The Journal of cell biology,
T H Carter, and
Z Z Milovanovic, and
L E Babiss, and
P B Fisher
May 1988,
European journal of immunology,
T H Carter, and
Z Z Milovanovic, and
L E Babiss, and
P B Fisher
September 2000,
Neuroreport,
T H Carter, and
Z Z Milovanovic, and
L E Babiss, and
P B Fisher
August 1981,
Cell,
T H Carter, and
Z Z Milovanovic, and
L E Babiss, and
P B Fisher
May 1981,
Mutation research,
